New Delhi, Jan. 31 -- Biocon declared their Q3 results on 30 Jan, 2025, revealing a significant increase in topline revenue of 93.31% year-over-year (YoY). However, the company's profit saw a drastic decline of 96.2%, amounting to Rs.25.1 crore, despite revenue reaching Rs.7642.8 crore.

In comparison to the previous quarter, Biocon experienced impressive growth with revenue increasing by 112.87% and profit surging by 256.88%. This marks a notable rebound in revenue performance, although the profit decline remains a concern.

The Selling, general & administrative expenses showed a slight decline of 0.16% quarter-over-quarter (q-o-q), but increased by 9.36% year-over-year (Y-o-Y). This indicates that while the company managed to reduce som...